Clinical Trials Directory

Trials / Completed

CompletedNCT06013098

Effects of Different Oxygen Concentrations on Pulmonary Complications in Patients Undergoing Radical Resection of Esophageal Cancer

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
65 (actual)
Sponsor
China Medical University, China · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Radical operation of esophageal cancer is complicated and traumatic, and ventilation with one lung in lateral position and ventilation with both lungs after supine position requires long-term tracheal intubation and ventilator-assisted ventilation, and the incidence of postoperative pulmonary complications is high.

Detailed description

Therefore, we should explore the most appropriate lung protection ventilation strategy to reduce the occurrence of pulmonary complications. The recommended standard of international expert group on lung protective ventilation strategy points out that the lowest concentration of oxygen (≤40%) should be inhaled as much as possible during mechanical ventilation to maintain normal blood oxygen level (SpO2≥94%). If the mixed gas with low inhaled oxygen concentration can achieve ideal oxygen saturation and arterial oxygen partial pressure, it may reduce the postoperative pulmonary complications of the subjects. However, there are few reports on the influence of different oxygen concentrations on pulmonary complications in patients undergoing radical resection of esophageal cancer. This study intends to explore the influence of different oxygen concentrations on pulmonary complications in patients undergoing radical resection of esophageal cancer.

Conditions

Interventions

TypeNameDescription
DRUG30%Oxygen60%FiO2 in one lung ventilation and 30% FIO2 in both lungs ventilation
DRUG60%Oxygen100%FiO2 in one lung ventilation and 60% FIO2 in both lungs ventilation

Timeline

Start date
2023-09-06
Primary completion
2026-01-30
Completion
2026-03-06
First posted
2023-08-28
Last updated
2026-03-18

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06013098. Inclusion in this directory is not an endorsement.